| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VGN
|
2.76 | 2.1B | 1.06 | — | 0.92 | 62.8% | 8.1% | 84 | 85 | 7.14 | +119.2% | 79 | -6.55 |
|
KSC
|
3.06 | 418.1M | 4.59 | 1.11 | 2.03 | 5.0% | 12.6% | 73 | 48 | 5.15 | +51.2% | 70 | 0.34 |
|
ALX
|
4.59 | 6.7B | 25.71 | 2.15 | 22.64 | -0.5% | 10.2% | 34 | 18 | 2.11 | -37.3% | 62 | 0.56 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.